+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Seres Therapeutics Inc (MCRB) - Financial and Strategic SWOT Analysis Review

  • ID: 4278733
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Seres Therapeutics Inc (Seres), formerly Seres Health Inc is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’s lead development candidate, SER-109 is an oral microbiome therapeutic and bacterial spore ecology that is being developed for the prevention of recurrent clostridium difficile infection in adults. Seres’ SER-287 is an oral therapy for the treatment of ulcerative colitis, an inflammatory bowel disease. The company utilizes its microbiome therapeutics platform to identify key alterations in the microbiome that are associated with or lead to specific diseases. Seres is headquartered in Cambridge, Massachusetts, the US.

Seres Therapeutics Inc Key Recent Developments

Jan 31, 2018: Seres Therapeutics Names Eric D. Shaff to Additional Role of Chief Operating Officer
Nov 08, 2017: Seres Therapeutics Reports Third Quarter 2017 Financial Results
Aug 03, 2017: Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
Jul 10, 2017: Seres Therapeutics Strengthens Board of Directors with Appointment of Willard Dere, M.D., Former Amgen Chief Medical Officer
May 04, 2017: Seres Therapeutics Reports First Quarter 2017 Financial Results and Provides Update on Operational Progress

This comprehensive SWOT profile of Seres Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Seres Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Seres Therapeutics Inc - Key Information
  • Seres Therapeutics Inc - Overview
  • Seres Therapeutics Inc - Key Employees
  • Seres Therapeutics Inc - Key Employee Biographies
  • Seres Therapeutics Inc - Key Operational Heads
  • Seres Therapeutics Inc - Major Products and Services
  • Seres Therapeutics Inc - History
  • Seres Therapeutics Inc - Company Statement
  • Seres Therapeutics Inc - Locations And Subsidiaries
  • Seres Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Seres Therapeutics Inc - Business Description
  • Seres Therapeutics Inc - Corporate Strategy
  • Seres Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Seres Therapeutics Inc - Strengths
  • Seres Therapeutics Inc - Weaknesses
  • Seres Therapeutics Inc - Opportunities
  • Seres Therapeutics Inc - Threats
  • Seres Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Seres Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Seres Therapeutics Inc, Key Information
  • Seres Therapeutics Inc, Key Ratios
  • Seres Therapeutics Inc, Share Data
  • Seres Therapeutics Inc, Major Products and Services
  • Seres Therapeutics Inc, History
  • Seres Therapeutics Inc, Key Employees
  • Seres Therapeutics Inc, Key Employee Biographies
  • Seres Therapeutics Inc, Key Operational Heads
  • Seres Therapeutics Inc, Other Locations
  • Seres Therapeutics Inc, Subsidiaries
  • Seres Therapeutics Inc, Key Manufacturing facilities
  • Seres Therapeutics Inc, Key Competitors
  • Seres Therapeutics Inc, SWOT Analysis
  • Seres Therapeutics Inc, Ratios based on current share price
  • Seres Therapeutics Inc, Annual Ratios
  • Seres Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Seres Therapeutics Inc, Performance Chart
  • Seres Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown